This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
DMRT1 / Doublesex- and mab-3-related transcription factor 1 · IHC design guide
Design Immunohistochemistry for DMRT1
Plan chromogenic IHC for DMRT1 in paraffin sections using the catalog antibody’s validated conditions. Compare nuclear staining in a subset of spermatogonia with HPA tissue IHC observations, and assess unexpected staining cautiously because presumed off-target binding was reported (HPA tissue IHC).
Evidence assembled Oct 2026 · For research use; verify linked source records and product datasheet before use
DMRT1 Immunohistochemistry Experimental Design Guide
Expected localisation, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
Must know before staining
| Expected localisation | Nuclear in a subset of spermatogonia (HPA tissue IHC) | |
| Staining pattern | A subset of spermatogonia shows nuclear staining (HPA tissue IHC) | |
| Antigen retrieval | Citrate pH 6 HIER, heat-mediated (datasheet RP1083) | |
| Positive control | Testis | |
| Negative control | Adipose tissue+4 more · see all |
Important caveats
Reasons your staining may differ from the expected pattern.
| Fixation | Keep fixation conditions consistent across sections. (standard IHC practice; not target-specific) | |
| Caveat | Presumed off-target staining was disregarded (HPA tissue IHC) | |
| Regulation | Testis-specific expression (UniProt) | |
| Isoform / epitope | 3 isoforms; epitope coverage is unknown (UniProt) |
Section 1
Recommended DMRT1 IHC & IF Protocols
The catalog antibody’s paraffin IHC protocol is paired with a published chromogenic IHC protocol for orange-spotted grouper sections (PMC6529513).
| Sample | Paraffin-embedded rat testis tissue; fixative not specified (datasheet RP1083) |
| Fixation | Image fixative and duration unreported (datasheet RP1083); verify before use. |
| Sectioning | 4–5 µm sections on charged slides (standard) |
| Deparaffinisation | Xylene, graded ethanol series to water (standard) |
| Antigen retrieval | Heat retrieval: Citrate pH 6, 20 min (datasheet RP1083) |
| Peroxidase block | 3% H2O2, 10 min, room temperature (standard) |
| Blocking | 10% goat serum (datasheet RP1083) |
| Primary antibody | Rabbit anti-DMRT1, 0.5-1μg/ml (datasheet RP1083) |
| Primary incubation | Overnight at 4 °C (datasheet RP1083) |
| Detection | Streptavidin-biotin complex (SABC), DAB chromogen (datasheet RP1083) |
| Counterstain | Hematoxylin, blue, dehydrate and mount (standard) |
| Expected result | DMRT1-positive staining in preleptotene spermatocytes of testis (HPA tissue IHC: High). HPA tissue profile: Nuclear expression in a subset spermatogonia. No signal in the no-primary control. |
💡Decision noteStart with heat-mediated citrate pH 6 retrieval for the catalog antibody (datasheet: RP1083); the published grouper excerpt does not specify retrieval (PMC6529513).
Section 2
What Is the Expected DMRT1 Staining Pattern?
DMRT1 is a nuclear transcription factor with no transmembrane segment (UniProt Q9Y5R6). In testis IHC, expect nuclear staining in a subset of spermatogonia (HPA tissue IHC profile); HPA also lists high staining in preleptotene spermatocytes (HPA tissue IHC). HPA rates the tissue pattern Enhanced, while noting medium agreement with RNA expression and presumed off-target staining that was disregarded (HPA tissue IHC).
| Distinct nuclear stain in some germ cells within testis, with neighboring cells unstained. | This fits the reported nuclear pattern in a subset of spermatogonia (HPA tissue IHC profile; UniProt Q9Y5R6). Do not require every germ cell to stain: HPA describes a subset and separately lists high staining in preleptotene spermatocytes (HPA tissue IHC). |
| Cytoplasmic or membrane-dominant stain, without convincing nuclear signal. | The dominant compartment conflicts with the annotated nuclear location (UniProt Q9Y5R6) and observed testis pattern (HPA tissue IHC). Treat it as suspect, then compare morphology and a no-primary control; background or detection artefact cannot be identified from location alone (general IHC practice). |
| Strong stain in adipocytes or other cells listed as unstained by HPA. | HPA reports no detection in adipocytes from adipose tissue and breast, among its negative examples (HPA tissue IHC). Such staining raises concern for cross-reactivity or endogenous detection activity, especially if a no-primary control also stains; it does not establish a new DMRT1 expression site (general IHC practice). |
| Broad, hazy stain obscures nuclei across the section. | Diffuse colour makes nuclear localisation and cell-level scoring unreliable (general IHC practice). Assess a no-primary control and the distribution of precipitate; excessive detection signal or insufficient washing are possible general workflow causes, not DMRT1-specific effects (general IHC practice). |
| No nuclear signal in an otherwise interpretable testis section. | Target-specific fixation effects are not established by the supplied assay evidence. Verify with a matched IHC source before attributing a result to fixation. |
💡Expected DMRT1 appearanceCall a positive result when distinct nuclear staining appears in a subset of testis germ cells, with HPA listing high staining in preleptotene spermatocytes; widespread cytoplasmic colour or staining in HPA-negative cells is suspect (HPA tissue IHC; UniProt Q9Y5R6).
| Cell population and scoring | Score nuclear signal by cell type rather than averaging the whole section: HPA describes a subset of spermatogonia and lists preleptotene spermatocytes as high (HPA tissue IHC). The two HPA descriptions should be reported as given, without assuming they identify the same cells. |
| IHC evidence and antibody choice | HPA rates its tissue IHC reliability Enhanced and lists antibody HPA027850 as IHC Enhanced (HPA tissue IHC; HPA antibodies). HPA also notes medium agreement with RNA and disregarded presumed off-target binding; an unexpected pattern still needs controls (HPA tissue IHC; general IHC practice). |
| Intracellular location and processing | A nuclear result is biologically consistent with DMRT1's annotated location and transcription-factor function (UniProt Q9Y5R6). UniProt lists no transmembrane segment, signal peptide or propeptide, and one chain spanning residues 1–373; these annotations do not predict a fixation or retrieval response (UniProt Q9Y5R6). |
| Molecular variants | UniProt lists 3 isoforms and phosphoserine at residue 339 (UniProt Q9Y5R6). The supplied records do not map an antibody epitope or establish isoform-specific staining, phosphorylation-dependent staining, or a preferred retrieval condition; avoid explaining a slide pattern by those mechanisms. |
| Situation | Likely cause | Next action |
|---|---|---|
| Expected testis nuclei are unstained. | The assay may have failed, or the sampled area may lack the reported positive population (HPA tissue IHC; general IHC practice). | Locate appropriate germ cells on the counterstained section; compare a known-positive testis control and follow the IHC-validated antibody procedure before interpreting absence (general IHC practice). |
| Only cytoplasmic or membrane-like colour appears. | That distribution conflicts with nuclear DMRT1 (UniProt Q9Y5R6); nonspecific or detection-derived colour remains possible (general IHC practice). | Compare the stained section with a no-primary control, inspect nuclear boundaries, and score only reproducible nuclear signal in the expected cells (general IHC practice; HPA tissue IHC). |
| HPA-negative cell types stain strongly. | Cross-reactivity or endogenous detection activity is possible; HPA reports several unstained cell types, including adipocytes (HPA tissue IHC; general IHC practice). | Check a no-primary control and tissue morphology, then confirm any proposed new positive pattern independently before assigning it to DMRT1 (general IHC practice). |
| Diffuse chromogen obscures the nuclei. | Excess detection signal or inadequate washing can obscure cell-level localisation (general IHC practice). | Review reagent exposure and washes, compare the no-primary control, and adjust the general IHC workflow until nuclear boundaries can be judged (general IHC practice). |
| Testis stains, but nearly every cell appears positive. | HPA reports a subset pattern, so widespread staining exceeds the reported distribution (HPA tissue IHC). | Recheck cell identification and background controls; record the observed distribution separately from the HPA pattern rather than scoring all colour as specific (general IHC practice; HPA tissue IHC). |
| IF/ICC shows a pattern different from IHC. | HPA provides no DMRT1 ICC-IF images or validated main subcellular location in this payload (HPA subcellular); UniProt annotates nuclear location (UniProt Q9Y5R6). | Treat the IF/ICC result as unconfirmed here and use its dedicated guide for assay design; this section establishes no IF/ICC protocol or image-based validation (HPA subcellular). |
Experiment evidence
IHC & IF images showing DMRT1 staining
RP1083 · IHCIHC analysis of DMRT1 using anti-DMRT1 antibody (RP1083). DMRT1 was detected in paraffin-embedded section of rat testis tissue. Heat mediate
RP1083 · IHCIHC analysis of DMRT1 using anti-DMRT1 antibody (RP1083). DMRT1 was detected in paraffin-embedded section of mouse testis tissue. Heat media
HPA · Cerebral cortexHuman Protein Atlas IHC, Cerebral cortex. Source: https://www.proteinatlas.org/ENSG00000137090-DMRT1/tissue/cerebral+cortex#imid_7958739
HPA · ColonHuman Protein Atlas IHC, Colon. Source: https://www.proteinatlas.org/ENSG00000137090-DMRT1/tissue/colon#imid_7892766
HPA · LiverHuman Protein Atlas IHC, Liver. Source: https://www.proteinatlas.org/ENSG00000137090-DMRT1/tissue/liver#imid_7892759
HPA · KidneyHuman Protein Atlas IHC, Kidney. Source: https://www.proteinatlas.org/ENSG00000137090-DMRT1/tissue/kidney#imid_7892768
← swipe / scroll for more images →
Real IHC / IF data behind the staining-pattern expectations in this section.
Sample controls for DMRT1 IHC & IF
🧪Run testis first: preleptotene spermatocytes should show nuclear staining (HPA: High in testis preleptotene spermatocytes; UniProt Q9Y5R6: nucleus). Use adipose tissue as a negative tissue (HPA: adipocytes Not detected); on the testis slide, compare staining with morphologically distinct cells that show only background signal, without assuming all other cell types are negative (HPA: preleptotene spermatocytes listed High).
Positive control tissue: Testis (Preleptotene spermatocytes, HPA High)
Negative control tissue: Adipose tissue (HPA Not detected)
ICC-IF cell lines (HPA subcellular resource): HPA carries no ICC-IF cell line for DMRT1; derive a cell-line control from the positive tissue's cell type (Preleptotene spermatocytes) and confirm it by RNA or western blot first.
Technical controls: Include a no-primary, secondary-only control and a rabbit isotype control matched to the primary antibody’s clonality when known (caption: rabbit anti-DMRT1 RP1083); use DMRT1-knockout tissue as a biological negative if available. For testis sections developed with SABC and DAB, quench endogenous peroxidase and block endogenous biotin (caption: rat testis, SABC and DAB).
⚠️Feasibility: A target-specific fixation window or fixation effect is unreported, and the selected RP1083 tissue-IHC caption does not state the fixative (caption: fixative not stated). The rat testis paraffin-section example used citrate retrieval at pH 6 for 20 minutes, but it does not establish whether retrieval is required for all specimens (caption: RP1083 rat testis IHC). The supplied evidence does not establish whether frozen sections or IF are easier; endogenous peroxidase or biotin can complicate interpretation of the SABC/DAB testis example (caption: rat testis, SABC and DAB).
HPA tissue IHC evidence for DMRT1
Comprehensive Human Protein Atlas IHC scoring per tissue (reliability: Enhanced — Medium consistency between antibody staining and RNA expression data. Presumed off target binding observed and disregarded.). Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
Positive expression · recommended positive controls
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Testis | Preleptotene spermatocytes | High | Protein (IHC) | HPA → |
Undetected expression · recommended negative controls
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | Adipocytes | Not detected | Protein (IHC) | HPA → |
| Adrenal gland | Glandular cells | Not detected | Protein (IHC) | HPA → |
| Appendix | Glandular cells | Not detected | Protein (IHC) | HPA → |
| Bone marrow | Hematopoietic cells | Not detected | Protein (IHC) | HPA → |
| Breast | Adipocytes | Not detected | Protein (IHC) | HPA → |
Section 3
Advanced DMRT1 IHC Tips
Troubleshoot DMRT1 staining in paraffin sections by checking retrieval, nuclear localisation, cell identity and controls before interpreting chromogenic signal.
What retrieval should I try first when DMRT1 nuclear staining is weak?
Use heat-mediated citrate buffer at pH 6 for 20 minutes as the starting retrieval condition for RP1083 (RP1083 tissue-IHC caption). The demonstrated section was paraffin-embedded rat testis; its fixative was not reported, so document your specimen processing before comparing staining intensity (RP1083 tissue-IHC caption). If nuclear staining remains weak, adjust heating or cooling within your laboratory's validated retrieval workflow and compare sections processed together (standard IHC practice). Assess recovery in the expected testicular cell populations, while checking that stronger retrieval has not increased diffuse staining or damaged morphology (HPA: nuclear expression in a subset of spermatogonia; standard IHC practice).
How should I troubleshoot variable DMRT1 staining across differently fixed sections?
Target-specific fixation sensitivity is unknown here: the RP1083 paraffin-section caption does not state a fixative or fixation time (RP1083 tissue-IHC caption). Record each specimen's fixative, fixation duration, processing history and section age before comparing nuclear signal across batches (standard IHC practice). Keep the antibody concentration and retrieval condition constant initially—1 µg/mL antibody and citrate pH 6 for 20 minutes match the demonstrated staining conditions (RP1083 tissue-IHC caption). If a batch is weak, compare matched positive tissue processed alongside it and change one preparation variable at a time; do not assign the difference to a DMRT1-specific fixation effect without direct evidence (standard IHC practice).
How do I decide whether unexpected cytoplasmic DMRT1 staining is credible?
DMRT1 is annotated as nuclear and has no transmembrane segment, making nuclear staining the primary localisation to assess (UniProt Q9Y5R6: subcellular location and topology). In tissue, the reported pattern is nuclear expression in a subset of spermatogonia, while HPA also reports high staining in preleptotene spermatocytes (HPA: tissue IHC profile and positive cell entry). Check the counterstain and morphology to verify that chromogen lies within nuclei rather than over adjacent cytoplasm or overlapping cells (standard IHC practice). If cytoplasmic colour dominates, review retrieval, antibody concentration, detection background and negative controls before calling it a new DMRT1 localisation (standard IHC practice).
Could isoforms or epitope position explain inconsistent DMRT1 staining?
DMRT1 has 3 listed isoforms, but the supplied RP1083 caption does not define its epitope or establish which isoforms it detects (UniProt Q9Y5R6: isoforms; RP1083 tissue-IHC caption). Check the antibody's documented immunogen or epitope against the sequence of each isoform before interpreting staining differences as splice-form differences (standard IHC practice). A phosphoserine is annotated at residue 339, yet no supplied evidence links that modification to RP1083 recognition or retrieval behaviour (UniProt Q9Y5R6: modified residues; RP1083 tissue-IHC caption). If comparisons remain important, use an independently validated antibody with a documented epitope and score matched sections under identical processing conditions (standard IHC practice).
How should I adapt the DMRT1 localisation check for multiplex IF?
Use a testicular cell-type marker in a separate channel to help identify the stained population, and assess whether DMRT1 signal overlaps nuclei in the expected cells (HPA: nuclear expression in a subset of spermatogonia; standard IF practice). Choose fluorophores and filters after inspecting unstained tissue autofluorescence, reserving a spectrally cleaner channel for the weaker signal (standard IF practice). Because DMRT1 is nuclear and has no transmembrane segment, optimise permeabilisation for access to an intracellular nuclear epitope while retaining morphology (UniProt Q9Y5R6: subcellular location and topology; standard IF practice). Include single-label and secondary-only controls to assess channel bleed-through and background; the RP1083 paraffin IHC caption supplies no IF-specific staining conditions (standard IF practice; RP1083 tissue-IHC caption).
What should I check when DAB obscures DMRT1-positive nuclei?
The RP1083 example used 1 µg/mL primary antibody, 10% goat serum block, a biotinylated secondary and DAB chromogen (RP1083 tissue-IHC caption). Compare a no-primary control and inspect whether colour arises in the detection system, at tissue edges, or broadly outside nuclei (standard IHC practice). Apply a peroxidase block for a peroxidase-based DAB workflow, and check the contribution of biotin-dependent detection where relevant; these are general workflow controls, not demonstrated DMRT1-specific requirements (standard IHC practice). If background persists, titrate the primary and secondary separately and adjust washing or chromogen development while retaining a matched positive testis control (standard IHC practice; UniProt Q9Y5R6: tissue specificity).
How should I quantify DMRT1 staining when only some cells are positive? ⚠ ANSWER MARKED FOR VERIFICATION
Define the cell population and nuclear positivity threshold before scoring, since HPA describes nuclear staining in a subset of spermatogonia and reports high staining in preleptotene spermatocytes (HPA: tissue IHC profile and positive cell entry). Report the percentage of positive nuclei among morphologically identified cells, or an H-score if nuclear intensity categories are reproducible (standard IHC practice). For spatial comparisons, report positive nuclei per mm² of evaluable tissue and normalise to the counted cell population or sampled area, as appropriate (standard IHC practice). Keep section processing, imaging, thresholding and exclusion of damaged regions consistent across groups, and document the number of cells or fields assessed (standard IHC practice).
Which staining patterns support a true DMRT1 result rather than artefact?
A credible result places signal in nuclei of the expected testicular cell population, consistent with DMRT1's nuclear annotation and the HPA tissue pattern (UniProt Q9Y5R6: subcellular location; HPA: tissue IHC profile). Strong staining in an unexpected compartment or cell type needs independent verification, particularly because HPA reports presumed off-target binding that was disregarded in its reliability assessment (HPA: Enhanced reliability description; standard IHC practice). Exclude edge-associated colour, necrotic areas and endogenous enzyme signal using morphology and appropriate no-primary or detection controls (standard IHC practice). Compare positives with matched negative tissue cautiously: HPA reports DMRT1 as not detected in several non-testicular cell populations, but that does not validate every negative specimen or assay condition (HPA: tissue IHC negative entries; standard IHC practice).
Boster reagents
Best DMRT1 / Doublesex- and mab-3-related transcription factor 1 IHC Antibodies
RP1083 has real IHC images of paraffin testis sections from human, mouse, and rat (RP1083 IHC captions). No IF/ICC image or application is listed (catalog applications; image alts).
Real IHC data
Anti-DMRT1 Antibody ®
Cat # RP1083
RP1083 is listed for IHC in human, mouse, and rat (catalog applications and reactivity). Its IHC captions show paraffin testis sections from all three species; no IF/ICC validation is shown (RP1083 IHC and IF image alts).
Which to pick: For tissue IHC, choose RP1083: its captions document staining of paraffin testis sections, while the fixative is unreported (RP1083 IHC captions). For IF/ICC, there is no validated choice in this catalog because RP1083 lists IHC and WB only, has no IF image, and reports no clone (catalog applications, IF image alts, clone). For cross-species IHC, RP1083 covers human, mouse, and rat (catalog reactivity; RP1083 IHC captions).
Each figure is that product's own IHC / IF validation image from its datasheet.
References
- UniProt Consortium. UniProt entry Q9Y5R6 (DMRT1_HUMAN, Doublesex- and mab-3-related transcription factor 1).
- Human Protein Atlas. DMRT1 tissue IHC expression (reliability: Enhanced).
- Human Protein Atlas. DMRT1 subcellular location (ICC-IF): Highest expression in SuSa: 0.8 nTPM.
- Human Protein Atlas. DMRT1 antibody validation summary (1 antibodies).
- DMRT1 repression using a novel approach to genetic manipulation induces testicular dysgenesis in human fetal gonads. Human reproduction (Oxford, England) 2018 — PMC6195803.
- New Insights Into the Role of Follicle-Stimulating Hormone in Sex Differentiation of the Protogynous Orange-Spotted Grouper, Epinephelus coioides. Frontiers in endocrinology 2019 — PMC6529513.
- DMRT1 gene disruption alone induces incomplete gonad feminization in chicken. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2021 — PMC10266359.
- Sexually dimorphic expression of Dmrt1 and γH2AX in germ stem cells during gonadal development in Xenopus laevis. FEBS open bio 2016 — PMC4821358.
- PubMed PMID:10332030 — UniProt-cited evidence.
- PubMed PMID:10857744 — UniProt-cited evidence.
- PubMed PMID:16617334 — UniProt-cited evidence.
Immunohistochemistry protocol sheet for DMRT1 (Doublesex- and mab-3-related transcription factor 1). Expected localisation Nuclear in a subset of spermatogonia (HPA tissue IHC). Antigen retrieval: Citrate pH 6 HIER, heat-mediated (datasheet RP1083). Validated IHC antibody: RP1083 at 0.5-1μg/ml (the product's own IHC validation image is shown). Controls (HPA): positive Testis (Preleptotene spermatocytes); negative Adipose tissue. IHC workflow; specimen preparation unspecified. Protocol steps: 1. Sample: Paraffin-embedded rat testis tissue; fixative not specified (datasheet RP1083); 2. Fixation: Image fixative and duration unreported (datasheet RP1083); verify before use.; 3. Sectioning: 4–5 µm sections on charged slides (standard); 4. Deparaffinisation: Xylene, graded ethanol series to water (standard); 5. Antigen retrieval: Heat retrieval: Citrate pH 6 , 20 min (datasheet RP1083); 6. Peroxidase block: 3% H2O2, 10 min , room temperature (standard); 7. Blocking: 10% goat serum (datasheet RP1083); 8. Primary antibody: Rabbit anti-DMRT1, 0.5-1μg/ml (datasheet RP1083); 9. Primary incubation: Overnight at 4 °C (datasheet RP1083). Watch for: Fixation: Keep fixation conditions consistent across sections. (standard IHC practice; not target-specific); Caveat: Presumed off-target staining was disregarded (HPA tissue IHC); Isoform / epitope: 3 isoforms; epitope coverage is unknown (UniProt); Regulation: Testis-specific expression (UniProt). Evidence: UniProt Q9Y5R6, HPA tissue IHC · Enhanced, HPA cell-line RNA · Highest expression in SuSa: 0.8 nTPM, Datasheet RP1083, PMC6529513. QR code links to https://www.bosterbio.com/bosterbio-gene-info-cards/DMRT1/immunohistochemistry-ihc-guide.